BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34432457)

  • 1. Evaluation of Multivalent Sialylated Polyglycerols for Resistance Induction in and Broad Antiviral Activity against Influenza A Viruses.
    Stadtmueller MN; Bhatia S; Kiran P; Hilsch M; Reiter-Scherer V; Adam L; Parshad B; Budt M; Klenk S; Sellrie K; Lauster D; Seeberger PH; Hackenberger CPR; Herrmann A; Haag R; Wolff T
    J Med Chem; 2021 Sep; 64(17):12774-12789. PubMed ID: 34432457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening.
    Weisshaar M; Cox R; Morehouse Z; Kyasa SK; Yan D; Oberacker P; Mao S; Golden JE; Lowen AC; Natchus MG; Plemper RK
    J Virol; 2016 Aug; 90(16):7368-7387. PubMed ID: 27252534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin-Inspired, High Molecular Weight Virus Binding Inhibitors Show Biphasic Binding Behavior to Influenza A Viruses.
    Wallert M; Nie C; Anilkumar P; Abbina S; Bhatia S; Ludwig K; Kizhakkedathu JN; Haag R; Block S
    Small; 2020 Nov; 16(47):e2004635. PubMed ID: 33135314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Flexible Sialylated Nanogels as Highly Potent Influenza A Virus Inhibitors.
    Bhatia S; Hilsch M; Cuellar-Camacho JL; Ludwig K; Nie C; Parshad B; Wallert M; Block S; Lauster D; Böttcher C; Herrmann A; Haag R
    Angew Chem Int Ed Engl; 2020 Jul; 59(30):12417-12422. PubMed ID: 32441859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.
    Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J
    Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
    Zhao X; Li R; Zhou Y; Xiao M; Ma C; Yang Z; Zeng S; Du Q; Yang C; Jiang H; Hu Y; Wang K; Mok CKP; Sun P; Dong J; Cui W; Wang J; Tu Y; Yang Z; Hu W
    J Med Chem; 2018 Jun; 61(12):5187-5198. PubMed ID: 29799746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
    Job ER; Bottazzi B; Gilbertson B; Edenborough KM; Brown LE; Mantovani A; Brooks AG; Reading PC
    PLoS One; 2013; 8(3):e59623. PubMed ID: 23544079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
    Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
    Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
    J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
    Ma C; Li F; Musharrafieh RG; Wang J
    Antiviral Res; 2016 Sep; 133():62-72. PubMed ID: 27478032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.
    Motohashi Y; Igarashi M; Okamatsu M; Noshi T; Sakoda Y; Yamamoto N; Ito K; Yoshida R; Kida H
    Virol J; 2013 Apr; 10():118. PubMed ID: 23587221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance.
    Hensley SE; Das SR; Gibbs JS; Bailey AL; Schmidt LM; Bennink JR; Yewdell JW
    PLoS One; 2011 Feb; 6(2):e15190. PubMed ID: 21364978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.
    Derksen A; Hensel A; Hafezi W; Herrmann F; Schmidt TJ; Ehrhardt C; Ludwig S; Kühn J
    PLoS One; 2014; 9(10):e110089. PubMed ID: 25303676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding inhibition of various influenza viruses by sialyllactose-modified trimer DNAs.
    Yamabe M; Kaihatsu K; Ebara Y
    Bioorg Med Chem Lett; 2019 Mar; 29(5):744-748. PubMed ID: 30655214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
    McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
    Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
    Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
    Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
    Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
    Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.